Biotechnology Draws Record Profit as Research Money Slows

Biotechnology companies worldwide boosted profit by 37 percent to a record $5.2 billion in 2012, partly by tempering growth in research-and-development spending, according to Ernst & Young.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.